MA Rastegar, A Végh, JG Papp… - … drugs and therapy, 2000 - pubmed.ncbi.nlm.nih.gov
The aim of the present study was to examine the effects of atrial natriuretic peptide (ANP) on the responses to coronary artery occlusion. In chloralose-urethane anaesthetised mongrel …
MA Rastegar, A Vegh, JG Papp… - … Drugs and Therapy, 2000 - search.proquest.com
The aim of the present study was to examine the effects of atrial natriuretic peptide (ANP) on the responses to coronary artery occlusion. In chloralose-urethane anaesthetised mongrel …
MA Rastegar, A Végh, JG Papp… - Cardiovascular Drugs and …, 2000 - europepmc.org
The aim of the present study was to examine the effects of atrial natriuretic peptide (ANP) on the responses to coronary artery occlusion. In chloralose-urethane anaesthetised mongrel …
MA RASTEGAR, A VEGH, JG PAPP… - … drugs and therapy, 2000 - pascal-francis.inist.fr
Atrial natriuretic peptide reduces the severe consequences of coronary artery occlusion in anaesthetized dogs CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
MA Rastegar, A Vegh, JG Papp, JR Parratt - Cardiovascular Drugs and …, 2000 - elibrary.ru
The aim of the present study was to examine the effects of atrial natriuretic peptide (ANP) on the responses to coronary artery occlusion. In chloralose-urethane anaesthetised mongrel …
MA Rastegar, Á Végh, JG Papp, JR Parratt - Cardiovascular Drugs and …, 2000 - infona.pl
The aim of the present study was to examine the effects of atrial natriuretic peptide (ANP) on the responses to coronary artery occlusion. In chloralose-urethane anaesthetised mongrel …
[引用][C]Atrial Natriuretic Peptide Reduces the Severe Consequences of Coronary Artery Occlusion in Anaesthetized Dogs
MA Rastegar, Á Végh, JG Papp, JR Parratt - Cardiovascular Drugs and …, 2000 - Springer
[引用][C]Atrial natriuretic peptide reduces the severe consequences of coronary artery occlusion in anaesthetized dogs
MA RASTEGAR, A VEGH, JG PAPP… - … drugs and therapy, 2000 - Springer